255 related articles for article (PubMed ID: 28691157)
1. Effect of vigabatrin on seizure control and safety profile in different subgroups of children with epilepsy.
Jackson MC; Jafarpour S; Klehm J; Thome-Souza S; Coughlin F; Kapur K; Loddenkemper T
Epilepsia; 2017 Sep; 58(9):1575-1585. PubMed ID: 28691157
[TBL] [Abstract][Full Text] [Related]
2. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
Camposano SE; Major P; Halpern E; Thiele EA
Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
[TBL] [Abstract][Full Text] [Related]
3. Clobazam: effect on frequency of seizures and safety profile in different subgroups of children with epilepsy.
Klehm J; Thome-Souza S; Sánchez Fernández I; Bergin AM; Bolton J; Harini C; Kadish NE; Libenson M; Peters J; Poduri A; Rotenberg A; Takeoka M; Bourgeois B; Loddenkemper T
Pediatr Neurol; 2014 Jul; 51(1):60-6. PubMed ID: 24830765
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of West syndrome].
Cvitanović-Sojat L; Gjergja R; Sabol Z; Hajnzić TF; Sojat T
Acta Med Croatica; 2005; 59(1):19-29. PubMed ID: 15813352
[TBL] [Abstract][Full Text] [Related]
5. Vigabatrin for Epileptic Spasms and Tonic Seizures in Tuberous Sclerosis Complex.
van der Poest Clement EA; Sahin M; Peters JM
J Child Neurol; 2018 Jul; 33(8):519-524. PubMed ID: 29687739
[TBL] [Abstract][Full Text] [Related]
6. The role of vigabatrin in childhood seizure disorders: results from a clinical audit.
Prasad AN; Penney S; Buckley DJ
Epilepsia; 2001 Jan; 42(1):54-61. PubMed ID: 11207785
[TBL] [Abstract][Full Text] [Related]
7. Ketogenic diet efficacy in the treatment of intractable epileptic spasms.
Kayyali HR; Gustafson M; Myers T; Thompson L; Williams M; Abdelmoity A
Pediatr Neurol; 2014 Mar; 50(3):224-7. PubMed ID: 24433856
[TBL] [Abstract][Full Text] [Related]
8. Focal Epilepsy in Children With Tuberous Sclerosis Complex: Does Vigabatrin Control Focal Seizures?
Lin S; Liao J; Zhao X; Hu Y; Chen L; Chen Y; Liu G; Yao Y; Su Q; Scheffer IE; Wen F
J Child Neurol; 2022 Apr; 37(5):329-333. PubMed ID: 35321578
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of vigabatrin in Japanese patients with infantile spasms: Primary short-term study and extension study.
Ohtsuka Y
Epilepsy Behav; 2018 Jan; 78():134-141. PubMed ID: 29190579
[TBL] [Abstract][Full Text] [Related]
10. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
[TBL] [Abstract][Full Text] [Related]
11. Vigabatrin in pediatric patients with refractory epilepsy.
Turanli G; Celebi A; Yalnizoğlu D; Topçu M; Topaloğlu H; Banu A; Aysun S
Turk J Pediatr; 2006; 48(1):25-30. PubMed ID: 16562782
[TBL] [Abstract][Full Text] [Related]
12. [Vigabatrin in childhood epilepsy--personal experience].
Zubcević S; Gavranović M; Catibusić F; Uzicanin S; Buljina A
Med Arh; 1999; 53(3 Suppl 2):63-5. PubMed ID: 10758766
[TBL] [Abstract][Full Text] [Related]
13. Dose-response study of vigabatrin in children with refractory epilepsy.
Herranz JL; Arteaga R; Farr IN; Valdizan E; Beaumont D; Armijo JA
J Child Neurol; 1991; Suppl 2():S45-51. PubMed ID: 1940124
[TBL] [Abstract][Full Text] [Related]
14. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms.
Askalan R; Mackay M; Brian J; Otsubo H; McDermott C; Bryson S; Boyd J; Snead C; Roberts W; Weiss S
J Child Neurol; 2003 Mar; 18(3):165-70. PubMed ID: 12731640
[TBL] [Abstract][Full Text] [Related]
15. Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial.
Kotulska K; Kwiatkowski DJ; Curatolo P; Weschke B; Riney K; Jansen F; Feucht M; Krsek P; Nabbout R; Jansen AC; Wojdan K; Sijko K; Głowacka-Walas J; Borkowska J; Sadowski K; Domańska-Pakieła D; Moavero R; Hertzberg C; Hulshof H; Scholl T; Benova B; Aronica E; de Ridder J; Lagae L; Jóźwiak S;
Ann Neurol; 2021 Feb; 89(2):304-314. PubMed ID: 33180985
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and tolerability of vigabatrin in West syndrome].
Moraes MH; Montenegro MA; Franzon RC; Avila JO; Guerreiro MM
Arq Neuropsiquiatr; 2005 Jun; 63(2B):469-73. PubMed ID: 16059600
[TBL] [Abstract][Full Text] [Related]
17. [Long-term follow-up of childhood epilepsy treated with vigabatrin outside of clinical trials].
Garaizar C; Martínez-González MJ; Fernández-Cuesta MA; Prats JM
Rev Neurol; 1999 Aug 1-15; 29(3):201-7. PubMed ID: 10797902
[TBL] [Abstract][Full Text] [Related]
18. Vigabatrin for childhood partial-onset epilepsies.
Greiner HM; Lynch ER; Fordyce S; Agricola K; Tudor C; Franz DN; Krueger DA
Pediatr Neurol; 2012 Feb; 46(2):83-8. PubMed ID: 22264701
[TBL] [Abstract][Full Text] [Related]
19. Vigabatrin and high-dose prednisolone therapy for patients with West syndrome.
Ko A; Youn SE; Chung HJ; Kim SH; Lee JS; Kim HD; Kang HC
Epilepsy Res; 2018 Sep; 145():127-133. PubMed ID: 29966811
[TBL] [Abstract][Full Text] [Related]
20. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.
Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP;
Lancet Neurol; 2005 Nov; 4(11):712-7. PubMed ID: 16239177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
